- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03639792
Escorting Octogenarian for Gastric Cancer Surgery
May 21, 2020 updated by: BIRENDRA KUMAR SAH, Ruijin Hospital
An objective analysis of postoperative complications is vital to escort octogenarian for gastric cancer surgery.
Investigator carefully collected clinical data prospectively to pave way for standard management in high risk patients.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
An objective analysis of postoperative complications is vital to escort octogenarian for gastric cancer surgery.
Investigator carefully collected clinical data prospectively to pave way for standard management in high risk patients.
Detailed data on surgical indication, assessment for proposed surgery and perioperative management are analyzed for future guidelines in senile.
Study Type
Observational
Enrollment (Actual)
61
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 200025
- Ruijin Hospital Shanghai Jiaotong University School of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
80 years to 90 years (Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
A cohort of gastric cancer patients who underwent surgery during two consecutive years in a Chinese hospital.
Description
Inclusion Criteria:
- Pathologically confirmed gastric cancer patients Clinically fit for gastric cancer surgery
Exclusion Criteria:
- Non gastric cancer patients Clinically unfit for gastric cancer surgery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative Morbidity and mortality
Time Frame: One month after hospital discharge
|
Postoperative Morbidity and mortality according to standard definition
|
One month after hospital discharge
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Overall survival
Time Frame: upto two years
|
Overall survival
|
upto two years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2016
Primary Completion (Actual)
December 31, 2017
Study Completion (Actual)
December 31, 2017
Study Registration Dates
First Submitted
August 17, 2018
First Submitted That Met QC Criteria
August 17, 2018
First Posted (Actual)
August 21, 2018
Study Record Updates
Last Update Posted (Actual)
May 22, 2020
Last Update Submitted That Met QC Criteria
May 21, 2020
Last Verified
August 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RJ-GC-Postop-complication 2
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastric Cancer
-
City of Hope Medical CenterCompletedGastric Cancer | Gastric Adenocarcinoma | Gastric Cancer Stage IV | Gastric Neoplasm | Gastric Cancer Metastatic to Lung | Gastric Cancer Stage | Gastric Cancer Metastatic to Liver | Gastric Cancer Stage III | Gastric Cancer Stage II | Gastric Lesion | Gastric Cancer in Situ | Gastric Cancer Stage IIIB | Gastric... and other conditionsUnited States, Japan
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingGastric Adenocarcinoma | Clinical Stage III Gastric Cancer AJCC v8 | Clinical Stage 0 Gastric Cancer AJCC v8 | Clinical Stage I Gastric Cancer AJCC v8 | Clinical Stage II Gastric Cancer AJCC v8 | Clinical Stage IIA Gastric Cancer AJCC v8 | Clinical Stage IIB Gastric Cancer AJCC v8 | Pathologic Stage... and other conditionsUnited States
-
City of Hope Medical CenterCompletedAdenocarcinoma of the Gastroesophageal Junction | Stage IV Gastric Cancer | Recurrent Gastric Cancer | Diffuse Adenocarcinoma of the Stomach | Intestinal Adenocarcinoma of the Stomach | Mixed Adenocarcinoma of the Stomach | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric Cancer and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingGastric Adenocarcinoma | Clinical Stage III Gastric Cancer AJCC v8 | Clinical Stage I Gastric Cancer AJCC v8 | Clinical Stage IIA Gastric Cancer AJCC v8 | Clinical Stage IVA Gastric Cancer AJCC v8 | Pathologic Stage IB Gastric Cancer AJCC v8 | Pathologic Stage II Gastric Cancer AJCC v8 | Pathologic... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedGastric Adenocarcinoma | Stage IV Gastric Cancer | Stage II Gastric Cancer | Stage III Gastric CancerUnited States
-
Ukrainian Society of Clinical OncologyRecruitingGastric Cancer | Gastrectomy for Gastric Cancer | Gastric Cancer Stage III | Gastric Cancer Stage IIUkraine
-
Lin LiuRecruitingGastric Carcinoma | Gastric Neoplasm | Gastric Cancer Adenocarcinoma Metastatic | Gastric (cardia, Body) CancerChina
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)Active, not recruitingGastric Adenocarcinoma | Epstein-Barr Virus Positive | Mismatch Repair Protein Deficiency | Stage IB Gastric Cancer AJCC v7 | Stage II Gastric Cancer AJCC v7 | Stage IIA Gastric Cancer AJCC v7 | Stage IIB Gastric Cancer AJCC v7 | Stage III Gastric Cancer AJCC v7 | Stage IIIA Gastric Cancer AJCC v7 | Stage... and other conditionsUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedGastroesophageal Junction Adenocarcinoma | Gastric Cardia Adenocarcinoma | Stage IB Gastric Cancer AJCC v7 | Stage II Gastric Cancer AJCC v7 | Stage IIA Gastric Cancer AJCC v7 | Stage IIB Gastric Cancer AJCC v7 | Stage IIIA Gastric Cancer AJCC v7 | Stage IIIB Gastric Cancer AJCC v7United States
-
Ukrainian Society of Clinical OncologyRecruitingStomach Cancer | Gastric Cancer | Chemotherapy | Gastric Adenocarcinoma | Gastrectomy | Gastrointestinal Cancer | Gastroesophageal Junction Adenocarcinoma | Advanced Gastric Adenocarcinoma | GastroEsophageal Cancer | Stomach Neoplasm | Gastric Neoplasm | Advanced Gastric Carcinoma | Gastrectomy for Gastric Cancer | Advanced Gastroesophageal Junction Adenocarcinoma and other conditionsLithuania, Ukraine
Clinical Trials on gastric cancer surgery
-
Adana City Training and Research HospitalCompletedStomach Cancer | Corona Virus InfectionTurkey
-
West China HospitalUnknown
-
Karadeniz Technical UniversityCompleted
-
The Affiliated Hospital of Qingdao UniversityRecruiting
-
University of Roma La SapienzaUnknown
-
P. Herzen Moscow Oncology Research InstituteNational Medical Research Radiological Centre of the Ministry of Health of...Not yet recruitingStomach Cancer | Gastric Cancer | Siewert Type III Adenocarcinoma of Esophagogastric JunctionRussian Federation
-
P. Herzen Moscow Oncology Research InstituteNational Medical Research Radiological Centre of the Ministry of Health of...CompletedEsophageal Cancer | Oesophageal Cancer | Siewert Type I Adenocarcinoma of Esophagogastric Junction | Siewert Type III Adenocarcinoma of Esophagogastric JunctionRussian Federation, Belarus
-
Dong PengActive, not recruiting
-
Beijing Friendship HospitalRecruitingGastric Cancer | Esophagus CancerChina
-
First Affiliated Hospital of Chongqing Medical...Completed